Diana Drago-Garcia (Diana Drago)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Venues

Cancers

Science signaling

Oncogene

EMBO molecular medicine

Weizmann Institute of Science (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Weizmann Institute of Science Aug 17 2017

Israel

PHD :: Biological Regulation

Instituto Nacional de Medicina Genómica Aug 03 2015 - Jul 24 2017

Mexico

MSC :: Population Genomics

Publications

Ashish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster, Moshit Lindzen, Saptaparna Mukherjee, Rainer Will, Soma Ghosh, Arturo Simoni-Nieves, Aakanksha Verma, Rishita Chatterjee, Simone Borgoni, Welles Robinson, Sanju Sinha, Alexander Brandis, D Lucas Kerr, Wei Wu, Arunachalam Sekar, Suvendu Giri, Youngmin Chung, Diana Drago-Garcia, Brian P Danysh, Mattia Lauriola, Michelangelo Fiorentino, Andrea Ardizzoni, Moshe Oren, Collin M Blakely, Jideofor Ezike, Stefan Wiemann, Laxmi Parida, Trever G Bivona, Rami I Aqeilan, Joan S Brugge, Aviv Regev, Gad A Getz, Eytan Ruppin, Yosef Yarden
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer. Cancer discovery 12 (11) (2022)
Francesco Roncato, Ofer Regev, Sara W Feigelson, Sandeep Kumar Yadav, Lukasz Stanislaw Kaczmarczyk, Nehora Levi, Diana Drago-Garcia, Samuel Ovadia, Marina Kizner, Yoseph Addadi, João C Sabino, Yossi Ovadya, Sérgio Fernandes de Almeida, Ester Feldmesser, Gabi Gerlitz, Ronen Alon
Reduced Lamin A/C Does Not Facilitate Cancer Cell Transendothelial Migration but Compromises Lung Metastasis. Cancers 13 (10) (2021)
Ilaria Marrocco, Donatella Romaniello, Itay Vaknin, Diana Drago-Garcia, Roni Oren, Mary Luz Uribe, Nishanth Belugali Nataraj, Soma Ghosh, Raya Eilam, Tomer-Meir Salame, Moshit Lindzen, Yosef Yarden
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models. EMBO molecular medicine 13 (4) (2021)
Moshit Lindzen, Soma Ghosh, Ashish Noronha, Diana Drago-Garcia, Nishanth Belugali Nataraj, Orith Leitner, Silvia Carvalho, Einav Zmora, Stav Sapoznik, Keren Bahar Shany, Keren Levanon, Dan Aderka, Belinda Sánchez Ramírez, Maik Dahlhoff, Iain A McNeish, Yosef Yarden
Targeting autocrine amphiregulin robustly and reproducibly inhibits ovarian cancer in a syngeneic model: roles for wildtype p53. Oncogene 40 (21) (2021)
Mary Luz Uribe, Maik Dahlhoff, Rajbir Nath Batra, Nishanth Belugali Nataraj, Yuya Haga, Diana Drago-Garcia, Ilaria Marrocco, Arunachalam Sekar, Soma Ghosh, Itay Vaknin, Sacha Lebon, Lior Kramarski, Yasuo Tsutsumi, Inpyo Choi, Oscar M Rueda, Carlos Caldas, Yosef Yarden
TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis. Science signaling 14 (688) (2021)
Donatella Romaniello, Ilaria Marrocco, Nishanth Belugali Nataraj, Irene Ferrer, Diana Drago-Garcia, Itay Vaknin, Roni Oren, Moshit Lindzen, Soma Ghosh, Matthew Kreitman, Jeanette Clarissa Kittel, Nadege Gaborit, Gretchen Bergado Baez, Belinda Sanchez, Raya Eilam, Eli Pikarsky, Luis Paz-Ares, Yosef Yarden
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor. Cancers 12 (9) (2020)

Diana Drago-Garcia.css-eqlu8i{font-size:small;padding-left:4px;} (Diana Drago)

Publication Activity (10 Years)

Top Topics

Top Venues

Diana Drago-Garcia (Diana Drago)